EZH2 and myelodysplastic syndrome: Despite of EZH2 expression declines in loss of 7q karyotype, EZH2 or SFSR2 mutant patients (Nagata and Maciejewski, 2019; Sakhdari et al., 2022), the expression profile in general MDS patients had not been investigated.